Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
hypertenzia vrátane hypertenzných kríz
hypertension including hypertensive crises
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
u hypertenzných pacientov sa oba stavy liečia súbežne.
in hypertensive patients both conditions are treated concomitantly.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
klinický význam tohto zistenia u hypertenzných pacientov je nejasný.
the clinical relevance of this finding in hypertensive patients is unknown.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
- zníženie rizika cievnej mozgovej príhody u hypertenzných pacientov s hypertrofiou
-
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pri užívaní kyprolisu sa pozorovala hypertenzia vrátane hypertenznej krízy a hypertenzných naliehavých stavov.
hypertension, including hypertensive crisis and hypertensive emergency, has been observed with kyprolis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nežiaduce reakcie lieku uvedené nižšie sa zhromaždili zo všetkých klinických skúšaní zahŕňajúcich 5788 hypertenzných pacientov liečených telmisartanom.
the adverse drug reactions listed below have been accumulated from all clinical trials including 5788 hypertensive patients treated with telmisartan.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
nasledovný zoznam nežiaducich účinkov liečiva bol vypracovaný zo všetkých klinických skúšok zahrňujúcich 5788 hypertenzných pacientov liečených telmisartanom:
the following adverse drug reactions listed below have been accumulated from all clinical trials including 5788 hypertensive patients treated with telmisartan.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
obmedzené údaje naznačujú, že systémový klírens hydrochlorotiazidu je znížený u zdravých aj hypertenzných starších osôb v porovnaní s mladými zdravými dobrovoľníkmi.
limited data suggest that the systemic clearance of hydrochlorothiazide is reduced in both healthy and hypertensive elderly subjects compared to young healthy volunteers.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nižšie sú uvedené nežiaduce účinky, ktoré sa vyskytli v placebom kontrolovaných štúdiách, v ktorých 1 965 hypertenzných pacientov užívalo irbesartan.
the following presents the adverse drug reactions that were reported in placebo-controlled trials in which 1,965 hypertensive patients received irbesartan.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
„ zníženie rizika cievnej mozgovej príhody u hypertenzných pacientov s hypertrofiou ľavej srdcovej komory, čo je zdokumentované ekg “.
therefore, the proposed indication was considered approvable after a majority vote by the chmp plenum and is supported with the following wording: “ reduction of risk of stroke in hypertensive patients with left ventricular hypertrophy, documented by ecg”.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
nasledujúca tabuľka prezentuje nežiaduce účinky, ktoré sa vyskytli v placebo-kontrolovaných štúdiách, v ktorých 1 965 hypertenzných pacientov používalo irbesartan.
the following table presents the adverse drug reactions that were reported in placebo-controlled trials in which 1,965 hypertensive patients received irbesartan.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
u diabetických hypertenzných pacientov s chronickou renálnou insuficienciou a zjavnou proteinúriou boli hlásené nasledujúce ďalšie vedľajšie reakcie u > 2% pacientov a viac ako u placeba.
in diabetic hypertensive patients with chronic renal insufficiency and overt proteinuria, the following additional adverse reactions were reported in > 2% of patients and in excess of placebo:
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
u 1,7 % hypertenzných pacientov s pokročilým diabetickým ochorením obličiek liečených irbesartanom sa vyskytol pokles hemoglobínu*, ktorý nebol klinicky významný.
in 1.7 % of hypertensive patients with advanced diabetic renal disease treated with irbesartan, a decrease in haemoglobin*, which was not clinically significant, has been observed.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
u hypertenzných pacientov, ktorí majú jeden alebo viac rizikových faktorov pre vznik kardiovaskulárnej choroby, doxazosín sa nemá pri liečbe používať ako jediný liek prvej voľby hypertenzie, pretože tu hrozí zvýšené riziko rozvinutia srdcového zlyhania.
in hypertensive patients with one or more additional risk factors for cardiovascular disease, doxazosin should not be used as a single agent for the first-line treatment of hypertension due to a possible increased risk for development of heart failure.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
„ zníženie rizika cievnej mozgovej príhody u hypertenzných pacientov s hypertrofiou ľavej srdcovej komory, čo je zdokumentované ekg “, na fdc sa vzťahujú nasledujúce úvahy:
therefore, whilst the proposed indication for losartan monotherapy was considered approvable after a majority vote by the chmp plenum and is supported with the following wording: “ reduction of risk of stroke in hypertensive patients with left ventricular hypertrophy, documented by ecg”, the following considerations apply for the fdc:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
farmakokinetika irbesartanu sa hodnotila u 23 hypertenzných detí po podaní jednotlivej alebo opakovanej dennej dávky irbesartanu (2 mg/kg) až do maximálnej dennej dávky 150 mg počas štyroch týždňov.
the pharmacokinetics of irbesartan were evaluated in 23 hypertensive children after the administration of single and multiple daily doses of irbesartan (2 mg/kg) up to a maximum daily dose of 150 mg for four weeks.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Štúdie sa zúčastnilo 1715 hypertenzných pacientov s diabetom 2. typu, proteinúriou ≥ 900 mg/ deň a hladinou kreatinínu v sére 1, 0- 3, 0 mg/ dl, u ktorých sa skúmali dlhodobé účinky (v priemere 2, 6 roka) aprovelu na progresiu ochorenia obličiek a celkovú mortalitu.
in 1,715 hypertensive patients with type 2 diabetes, proteinuria ≥ 900 mg/ day and serum creatinine ranging from 1.0-3.0 mg/ dl, the long-term effects (mean 2.6 years) of aprovel on the progression of renal disease and all-cause mortality were examined.
Last Update: 2012-04-12
Usage Frequency: 4
Quality: